CentralCharts: Supercharge your portfolio with groundbreaking tools.

Regulatory News: TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE): Date Total number of shares Number of voting rights Theoretical (1) Exercisable (2) April 30, 2025 2,270,057,201 2,270,057,201 2,211,382,313 (1) In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all the shares to which voting rights are attached, including shares for which voting rights have been suspended. (2) Total number of exercisable voting rights, after deduction of...

NORTHAMPTON, MA / ACCESS Newswire / May 13, 2025 / At Gilead, we innovate for impact. This commitment helps us drive scientific solutions forward, reach more people in more places and protect the planet we all share. Read our 2024 Responsible Business and Impact Report to see how we're driving change and working toward our vision to create a healthier world for all people. https://www.gilead.com/company/annual-impact-reports Gilead Sciences Gilead Sciences, Inc. is a research-based...

EQS-News: freenet AG / Key word(s): AGM/EGM freenet AGM approves record dividend per share of EUR 1.97 13.05.2025 / 14:50 CET/CEST The issuer is solely responsible for the content of this announcement. freenet AGM approves record dividend per share of EUR 1.97 freenet increases dividend per share by 11.3% to EUR 1.97 (prior year: EUR 1.77) Dividend yield 1 stands at 7.2% (prior year: 7.0 %) Other agenda items adopted by a large majority Büdelsdorf, 13 May 2025 - At the Annual General Meeting of...

Savers Value Village, Inc. (the “ Company ”) (NYSE: SVV), the largest for-profit thrift operator in the United States (“U.S.”) and Canada for value priced pre-owned clothing, accessories and household goods, today announced the commencement of a proposed secondary public offering (the “ Offering ”) of 15,000,000 shares of its common stock offered by certain funds, investment vehicles or accounts managed or advised by Ares Management LLC or its affiliates (the “ Ares Selling...

Promising results from the first-in-human study demonstrated that, at three-years post implantation, VenoValve remained safe and effective--achieving a high rate of patency, restoring deep venous competence and maintaining clinical benefits Company has submitted PMA application for the VenoValve to the U.S. Food and Drug Administration (FDA) with a decision anticipated in the second half of 2025 IRVINE, CA / ACCESS Newswire / May 13, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or...

Offers a Significant Premium of 61% to TrueBlue Stockholders HireQuest's High-Margin Franchising Model to drive near-term profitability and enhanced value for shareholders GOOSE CREEK, SC / ACCESS Newswire / May 13, 2025 / HireQuest, Inc. (NASDAQ:HQI) announced today that it has submitted to the Board of Directors of TrueBlue, Inc. (NYSE:TBI) a proposal to acquire all of the outstanding shares of common stock of TrueBlue for $7.50 per share. The consideration would be paid in registered shares...

New agreement broadens telehealth services to additional hospitals, addressing capacity challenges and enhancing virtual care standards across Prime Healthcare's national network. NEW YORK, NY AND ONTARIO, CA / ACCESS Newswire / May 13, 2025 / Equum Medical and Prime Healthcare have announced the renewal and expansion of their successful telehealth partnership, celebrating five years of collaboration in advancing virtual care delivery. Under the renewed agreement, Prime Healthcare will broaden...